Literature DB >> 26574931

miR-155 targets Caspase-3 mRNA in activated macrophages.

Rebecca De Santis1, Anke Liepelt1,2, Jana C Mossanen1, Anne Dueck3, Nadine Simons1, Antje Mohs2, Christian Trautwein2, Gunter Meister3, Gernot Marx1, Antje Ostareck-Lederer1, Dirk H Ostareck1.   

Abstract

To secure the functionality of activated macrophages in the innate immune response, efficient life span control is required. Recognition of bacterial lipopolysaccharides (LPS) by toll-like receptor 4 (TLR4) induces downstream signaling pathways, which merge to induce the expression of cytokine genes and anti-apoptotic genes. MicroRNAs (miRNAs) have emerged as important inflammatory response modulators, but information about their functional impact on apoptosis is scarce. To identify miRNAs differentially expressed in response to LPS, cDNA libraries from untreated and LPS-activated murine macrophages were analyzed by deep sequencing and regulated miRNA expression was verified by Northern blotting and qPCR. Employing TargetScan(TM) we identified CASPASE-3 (CASP-3) mRNA that encodes a key player in apoptosis as potential target of LPS-induced miR-155. LPS-dependent primary macrophage activation revealed TLR4-mediated enhancement of miR-155 expression and CASP-3 mRNA reduction. Endogenous CASP-3 and cleaved CASP-3 protein declined in LPS-activated macrophages. Accumulation of miR-155 and CASP-3 mRNA in miRNA-induced silencing complexes (miRISC) was demonstrated by ARGONAUTE 2 (AGO2) immunoprecipitation. Importantly, specific antagomir transfection effectively reduced mature miR-155 and resulted in significantly elevated CASP-3 mRNA levels in activated macrophages. In vitro translation assays demonstrated that the target site in the CASP-3 mRNA 3'UTR mediates miR-155-dependent Luciferase reporter mRNA destabilization. Strikingly, Annexin V staining of macrophages transfected with antagomir-155 and stimulated with LPS prior to staurosporine (SSP) treatment implied that LPS-induced miR-155 prevents apoptosis through CASP-3 mRNA down-regulation. In conclusion, we report that miR-155-mediated CASP-3 mRNA destabilization in LPS-activated RAW 264.7 macrophages suppresses apoptosis, as a prerequisite to maintain their crucial function in inflammation.

Entities:  

Keywords:  Caspase-3 mRNA; LPS; TLR4; macrophage activation; miR-155; post-transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 26574931      PMCID: PMC4829287          DOI: 10.1080/15476286.2015.1109768

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  62 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation.

Authors:  Anne Dueck; Alexander Eichner; Michael Sixt; Gunter Meister
Journal:  FEBS Lett       Date:  2014-01-18       Impact factor: 4.124

3.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival.

Authors:  Damiano Conte; Martin Holcik; Charles A Lefebvre; Eric Lacasse; David J Picketts; Kathryn E Wright; Robert G Korneluk
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

6.  Experimental identification of microRNA targets by immunoprecipitation of Argonaute protein complexes.

Authors:  Michaela Beitzinger; Gunter Meister
Journal:  Methods Mol Biol       Date:  2011

Review 7.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

8.  Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors.

Authors:  Shu-Rong Zheng; Gui-Long Guo; Qi Zhai; Zhang-Yong Zou; Wei Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2013

9.  MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1.

Authors:  Chun-Mei Zhang; Jing Zhao; Hua-Yu Deng
Journal:  J Biomed Sci       Date:  2013-10-24       Impact factor: 8.410

10.  Translation control of TAK1 mRNA by hnRNP K modulates LPS-induced macrophage activation.

Authors:  Anke Liepelt; Jana C Mossanen; Bernd Denecke; Felix Heymann; Rebecca De Santis; Frank Tacke; Gernot Marx; Dirk H Ostareck; Antje Ostareck-Lederer
Journal:  RNA       Date:  2014-04-21       Impact factor: 4.942

View more
  18 in total

1.  Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.

Authors:  Karishma Dhuri; Ravinder Reddy Gaddam; Ajit Vikram; Frank J Slack; Raman Bahal
Journal:  Cancer Res       Date:  2021-09-21       Impact factor: 12.701

2.  IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.

Authors:  Jie-Mei Wang; Yining Qiu; Zhao Yang; Hyunbae Kim; Qingwen Qian; Qinghua Sun; Chunbin Zhang; Lei Yin; Deyu Fang; Sung Hong Back; Randal J Kaufman; Ling Yang; Kezhong Zhang
Journal:  Sci Signal       Date:  2018-05-15       Impact factor: 8.192

3.  Identification of RNA-binding Proteins in Macrophages by Interactome Capture.

Authors:  Anke Liepelt; Isabel S Naarmann-de Vries; Nadine Simons; Katrin Eichelbaum; Sophia Föhr; Stuart K Archer; Alfredo Castello; Björn Usadel; Jeroen Krijgsveld; Thomas Preiss; Gernot Marx; Matthias W Hentze; Dirk H Ostareck; Antje Ostareck-Lederer
Journal:  Mol Cell Proteomics       Date:  2016-06-08       Impact factor: 5.911

4.  Propofol Regulates the TLR4/NF-κB Pathway Through miRNA-155 to Protect Colorectal Cancer Intestinal Barrier.

Authors:  Yuhua Gao; Tao Han; Cailing Han; Hua Sun; Xiaoxia Yang; Dongmei Zhang; Xinli Ni
Journal:  Inflammation       Date:  2021-06-03       Impact factor: 4.092

5.  miR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis.

Authors:  Jinshan Ye; Ruiwei Guo; Yankun Shi; Feng Qi; Chuanming Guo; Lixia Yang
Journal:  Mediators Inflamm       Date:  2016-10-24       Impact factor: 4.711

6.  Characterization of basal and lipopolysaccharide-induced microRNA expression in equine peripheral blood mononuclear cells using Next-Generation Sequencing.

Authors:  Nicholas J Parkinson; Virginia A Buechner-Maxwell; Sharon G Witonsky; R Scott Pleasant; Stephen R Werre; S Ansar Ahmed
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240

Review 7.  The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors.

Authors:  Recep Bayraktar; Maria Teresa Sabrina Bertilaccio; George A Calin
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

Review 8.  Tumour biomarkers-Tracing the molecular function and clinical implication.

Authors:  Jiahao Lin; Lie Ma; Di Zhang; Jiafeng Gao; Yipeng Jin; Zhihai Han; Degui Lin
Journal:  Cell Prolif       Date:  2019-03-14       Impact factor: 6.831

9.  MicroRNA-155 Promotes Myocardial Infarction-Induced Apoptosis by Targeting RNA-Binding Protein QKI.

Authors:  Jing Guo; Hui-Bin Liu; Chuan Sun; Xiu-Qing Yan; Juan Hu; Jie Yu; Ye Yuan; Zhi-Min Du
Journal:  Oxid Med Cell Longev       Date:  2019-05-05       Impact factor: 6.543

Review 10.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Authors:  Erika Larrea; Carla Sole; Lorea Manterola; Ibai Goicoechea; María Armesto; María Arestin; María M Caffarel; Angela M Araujo; María Araiz; Marta Fernandez-Mercado; Charles H Lawrie
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.